[Current trends in bladder cancer diagnosis].

Area of Science:

• Oncology
• Urology
• Medical Diagnostics

Background:

• Bladder cancer constitutes 2.8% of all malignant tumors in the Russian Federation.
• It is the second most common genitourinary cancer after prostate cancer.
• Non-muscle invasive bladder cancer has a high recurrence rate, potentially reaching 80%.

Purpose of the Study:

• To highlight the critical issue of non-muscle invasive bladder cancer recurrence.
• To emphasize the global focus on developing reliable early detection methods.
• To explore the potential of non-invasive diagnostics as a "golden" standard.

Main Methods:

• Review of current research on bladder cancer detection.
• Analysis of recurrence rates for non-muscle invasive bladder cancer.
• Discussion of advancements in non-invasive diagnostic technologies.

Main Results:

• High recurrence rates underscore the need for better monitoring.
• Significant global attention is directed towards early and non-invasive detection strategies.
• Non-invasive methods show promise in reducing the need for cystoscopies.

Conclusions:

• Developing reliable, non-invasive early detection methods for bladder cancer is crucial.
• These advancements could potentially lower the frequency of cystoscopies.
• Non-invasive diagnostics may become the new standard for bladder cancer detection.